Page last updated: 2024-10-25

cimetidine and Metaplasia

cimetidine has been researched along with Metaplasia in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gregory, MA1
Pettengell, KE1
Spitaels, JM1
Simjee, AE1

Other Studies

1 other study available for cimetidine and Metaplasia

ArticleYear
Alterations in the cytological composition of the juxta-scar villous mucosa after ulcer therapy with sucralfate or cimetidine.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1991, Nov-02, Volume: 80, Issue:9

    Topics: Cimetidine; Duodenal Ulcer; Duodenum; Humans; Intestinal Mucosa; Metaplasia; Sucralfate

1991